0001209191-21-003254.txt : 20210112
0001209191-21-003254.hdr.sgml : 20210112
20210112164926
ACCESSION NUMBER: 0001209191-21-003254
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210108
FILED AS OF DATE: 20210112
DATE AS OF CHANGE: 20210112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THOMAS FRANK E
CENTRAL INDEX KEY: 0001242616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38722
FILM NUMBER: 21524026
MAIL ADDRESS:
STREET 1: C/O ORCHARD THERAPEUTICS
STREET 2: 101 SEAPORT BOULEVARD, 7TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orchard Therapeutics plc
CENTRAL INDEX KEY: 0001748907
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
BUSINESS PHONE: 011-44-0-203-3846700
MAIL ADDRESS:
STREET 1: 108 CANNON STREET
CITY: LONDON
STATE: X0
ZIP: EC4N 6EU
FORMER COMPANY:
FORMER CONFORMED NAME: Orchard Rx Ltd
DATE OF NAME CHANGE: 20180802
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-08
0
0001748907
Orchard Therapeutics plc
ORTX
0001242616
THOMAS FRANK E
C/O ORCHARD THERAPEUTICS PLC
108 CANNON STREET
LONDON
X0
EC4N 6EU
UNITED KINGDOM
0
1
0
0
See Remarks
Ordinary Shares
2021-01-08
4
A
0
10667
0.00
A
35787
D
Ordinary Shares
2021-01-11
4
F
0
3706
6.72
D
32081
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On January 16, 2019, the Reporting Person was granted certain performance-based Restricted Share Units ("RSUs"), the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the first of three performance criteria was met, resulting in the vesting of 10,667 RSUs.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person.
Title: President & Chief Operating Officer
/s/ Frank Thomas
2021-01-12